Mass General’s ALS platform trial could find some of the first biomarkers for the disease
BioCentury,
An adaptive platform trial for ALS launched by Mass General could find new biomarkers to serve as surrogate endpoints or…
An adaptive platform trial for ALS launched by Mass General could find new biomarkers to serve as surrogate endpoints or…
Tai H, Cui L, Guan Y, Liu M, Li X, Huang Y, Yuan J, Shen D, Li D, Zhai F. Amyotrophic Lateral Sclerosis and Myasthenia Gravis…